DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
2	筋萎縮性側索硬化症	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2005-003248-75-IT (EUCTR)	31/08/2005	02/09/2005	PILOT STUDY ON SAFETY AND TOLERABILITY OF REPEATED MOBILIZATION PROCEDURES OF OSTEO-MEDULLARY DERIVED CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS	PILOT STUDY ON SAFETY AND TOLERABILITY OF REPEATED MOBILIZATION PROCEDURES OF OSTEO-MEDULLARY DERIVED CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS	SLOWING OF ALS PROGRESSION MedDRA version: 6.1;Level: PT;Classification code 10002026	Trade Name: MYELOSTIM 34*1FL 263MCG+1SIR INN or Proposed INN: Lenograstim	AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes			Italy

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

EUCTR2005-003248-75-IT
(EUCTR)

31/08/2005

02/09/2005

PILOT STUDY ON SAFETY AND TOLERABILITY OF REPEATED MOBILIZATION PROCEDURES OF OSTEO-MEDULLARY DERIVED CELLS IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS

SLOWING OF ALS PROGRESSION
MedDRA version: 6.1;Level: PT;Classification code 10002026

Trade Name: MYELOSTIM 34*1FL 263MCG+1SIR
INN or Proposed INN: Lenograstim

AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO

NULL

Authorised-recruitment may be ongoing or finished

Female: yes
Male: yes

Italy